Biomerica Inc (BMRA) stock
BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3047% below fair value
$1.32−0.04 (-2.94%)
Close on Nov 16, 2026Market cap $6.07MP/E –Yield –
Biomerica enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Biomerica's enterprise value was $4.21M on Nov 11, 2026, against $3.62M a year earlier. Over the last 5 years it ranged from $1.38M to $49.54M, with a median of $6.86M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.21M | +4.2% |
| 2025 | Dec 31, 2025 | $4.04M | +81.4% |
| 2024 | Dec 31, 2024 | $2.23M | -82.9% |
| 2023 | Dec 29, 2023 | $13.04M | -66.4% |
| 2022 | Dec 30, 2022 | $38.84M | -11.1% |
| 2021 | Dec 31, 2021 | $43.67M | -15.3% |
| 2020 | Dec 31, 2020 | $51.56M | +79.5% |
| 2019 | Dec 31, 2019 | $28.73M | +96.3% |
| 2018 | Dec 31, 2018 | $14.64M | -52.4% |
| 2017 | Dec 29, 2017 | $30.75M | +81.2% |
| 2016 | Dec 30, 2016 | $16.97M | +90.9% |
| 2015 | Dec 31, 2015 | $8.89M | +75.2% |
| 2014 | Dec 31, 2014 | $5.07M | +41.3% |
| 2013 | Dec 31, 2013 | $3.59M | -20.9% |
| 2012 | Dec 31, 2012 | $4.54M | +99.5% |
| 2011 | Dec 30, 2011 | $2.28M | – |
See a number that looks wrong?